Comorbidity as prognostic variable in MDS: comparative evaluation of the HCT-CI and CCI in a core dataset of 419 patients of the Austrian MDS Study GroupWolfgang R. Sperr, Peter Valent, Friedrich Wimazal et al.|Annals of Oncology|2009Cited by 117
Azacitidine for Front-Line Therapy of Patients with AML: Reproducible Efficacy Established by Direct Comparison of International Phase 3 Trial Data with Registry Data from the Austrian Azacitidine Registry of the AGMT Study GroupLisa Pleyer, Richard Greil, Andre C. Schuh et al.|International Journal of Molecular Sciences|2017Cited by 51